Skip to main content
SpringerLink
Log in

Novel Missense CAPN3 Mutation Responsible for Adult-Onset Limb Girdle Muscular Dystrophy with Calves Hypertrophy

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

CAPN3 gene encodes for calpain-3; this protein is a calcium-dependent intracellular protease. Deficiency of this enzyme leads to weakness of the proximal limb muscles and pelvic and shoulder girdles, the so-called limb-girdle muscular dystrophy type 2A (LGMD2A). Here, we reported the case of a Tunisian patient with LGMD2A associated with a novel missense mutation (c.T1681C/p.Y561H). A 61-year-old man, with consanguineous parents, was referred for gait difficulties and slowly progressive proximal weakness of the four limbs associated with moderate hypertrophy of the calves but his facial muscles were unaffected. Electromyography showed that the profile was myopathic pattern and creatine kinase (CK) level was high. Muscle biopsy processing included routine histological, immunohistochemical, and Western Blot reactions, using a panel of antibodies directed against dystrophin, dysferlin, calpain-3, sarcoglycan α, β, γ, and δ. For mutation analysis, we designed an NGS-based screening. Immunological analyses demonstrated a total deficiency in calpain-3 and δ-sarcoglycan, and a reduced expression of dysferlin. The genetic study yielded a homozygous missense mutation (c.T1681C) of the 13th exon of the CAPN3 gene. The mutation found in our patient (c.T1681C/p.Y561H) has not been previously reported. It is responsible for complete calpain-3 and δ-sarcoglycan deficiency and reduced dysferlin expression. The genetic study is mandatory in such cases with multiple-protein deficiency and ambiguous results of immune-histology and Western Blot studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Anderson LV, Harrison RM, Pogue R et al (2000) Secondary reduction in calpain 3 expression in patients with limb-girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies). Neuromuscul Disord 10:553–559.

    Article  CAS  Google Scholar 

  • Angelini C, Giaretta L, Marozzo R (2018) An update on diagnostic options and considerations in limb-girdle dystrophies. Expert Rev Neurother 18:693–703. https://doi.org/10.1080/14737175.2018.1508997

    Article  CAS  PubMed  Google Scholar 

  • Angelini C, Nardetto L, Borsato C, Padoan R, Fanin M, Nascimbeni AC, Tasca E (2010) The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B). Neurol Res 32:41–46. https://doi.org/10.1179/174313209X380847

    Article  CAS  PubMed  Google Scholar 

  • L Brenguier, I Richard, P Dinçer, C Roudaut, B Bady, J M Burgunder, R Chemaly, C A Garcia, G Halaby, C E Jackson, D M Kurnit, G Lefranc, C Legum, J Loiselet, L Merlini, A Nivelon-Chevallier, E Ollagnon-Roman, G Restagno, H Topaloglu, and J S Beckmann, (1997) Multiple independent molecular etiology for limb-girdle muscular dystrophy type 2A patients from various geographical origins. Am J Hum Genet. 60(5): 1128–1138.

  • Chae J1, Minami N, Jin Y, Nakagawa M, Murayama K, Igarashi F, Nonaka I. (2001). Calpain 3 gene mutations: genetic and clinico-pathologic findings in limbgirdle muscular dystrophy. Neuromuscul Disord (6-7):547-55.

    Article  CAS  Google Scholar 

  • Chrobáková T, Hermanová M, Kroupová I, Vondráček P, Mařı́ková T', Mazanec R, Zámečnı́k J, Staněk J, Havlová M, Fajkusová L (2004) Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcome. Neuromuscul Disord 14:659–665. https://doi.org/10.1016/j.nmd.2004.05.005

    Article  PubMed  Google Scholar 

  • de Paula F, Vainzof M, Passos-Bueno MR, de Cássia M Pavanello R, Matioli SR, V B Anderson L, Nigro V, Zatz M (2002) Clinical variability in calpainopathy: what makes the difference? Eur J Hum Genet 10:825–832. https://doi.org/10.1038/sj.ejhg.5200888

    Article  CAS  PubMed  Google Scholar 

  • Dinçer P1, Leturcq F, Richard I, Piccolo F, Yalnizoglu D, de Toma C, Akçören Z, Broux O, Deburgrave N, Brenguier L, Roudaut C, Urtizberea JA, Jung D, Tan E, Jeanpierre M, Campbell KP, Kaplan JC, Beckmann JS, Topaloglu H. (1997). A biochemical, genetic, and clinical survey of autosomal recessive limb girdle muscular dystrophies in Turkey. Ann Neurol 42(2):222-9.

    Article  CAS  Google Scholar 

  • Duguez S, Bartoli M, Richard I (2006) Calpain 3: a key regulator of the sarcomere? FEBS J 273:3427–3436. https://doi.org/10.1111/j.1742-4658.2006.05351.x

    Article  CAS  PubMed  Google Scholar 

  • Fadaee M, Kariminejad A, Fattahi Z, Nafissi S, Godarzi HR, Beheshtian M, Vazehan R, Akbari MR, Kahrizi K, Najmabadi H (2016) Report of limb-girdle muscular dystrophy type 2a in 6 Iranian patients, one with a novel deletion in CAPN3 gene. Neuromuscul Disord 26:277–282. https://doi.org/10.1016/j.nmd.2016.02.003

    Article  PubMed  Google Scholar 

  • Fanin M, Angelini C (2015) Protein and genetic diagnosis of limb-girdle muscular dystrophy type 2A: the yield and the pitfalls. Muscle Nerve 52:163–173. https://doi.org/10.1002/mus.24682

    Article  CAS  PubMed  Google Scholar 

  • Fanin M, Fulizio L, Nascimbeni AC, Spinazzi M, Piluso G, Ventriglia VM, Ruzza G, Siciliano G, Trevisan CP, Politano L, Nigro V, Angelini C (2004) Molecular diagnosis in LGMD2A: Mutation analysis or protein testing?. Human Mutation 24 (1):52-62.

    Article  CAS  Google Scholar 

  • Fanin M, Nascimbeni AC, Angelini C (2006) Screening of calpain-3 autolytic activity in LGMD muscle: a functional map of CAPN3 gene mutations. Journal of Medical Genetics 44 (1):38-43.

    Article  Google Scholar 

  • Fanin M, Nascimbeni AC, Fulizio L, Angelini C (2005) The frequency of limb-girdle muscular dystrophy 2A in northeastern Italy. Neuromuscul Disord 15:218–224. https://doi.org/10.1016/j.nmd.2004.11.003

    Article  PubMed  Google Scholar 

  • Fanin M, Nascimbeni AC, Tasca E, Angelini C (2009) How to tackle the diagnosis of limb-girdle muscular dystrophy 2A. European Journal of Human Genetics 17 (5):598-603.

    Article  Google Scholar 

  • Gregorio CC, Granzier H, Sorimachi H, Labeit S (1999) Muscle assembly: a titanic achievement? Curr Opin Cell Biol 11:18–25.

    Article  CAS  Google Scholar 

  • Groen EJ, Charlton R, Barresi R, Anderson LV, Eagle M, Hudson J, Koref MS, Straub V, Bushby KMD (2007) Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A. Brain 130:3237–3249. https://doi.org/10.1093/brain/awm259

    Article  PubMed  Google Scholar 

  • Guyon JR, Kudryashova E, Potts A, Dalkilic I, Brosius MA, Thompson TG, Beckmann JS, Kunkel LM, Spencer MJ (2003) Calpain 3 cleaves filamin C and regulates its ability to interact with gamma- and delta-sarcoglycans. Muscle Nerve 28:472–483. https://doi.org/10.1002/mus.10465

    Article  CAS  PubMed  Google Scholar 

  • Hadj Salem I, Kamoun F, Louhichi N, Rouis S, Mziou M, Fendri‑Kriaa N, Makni‑Ayadi F, Triki C, Fakhfakh F (2011) Mutations in LAMA2 and CAPN3 genes associated with genetic and phenotypic heterogeneities within a single consanguineous family involving both congenital and progressive muscular dystrophies. Biosci Rep 31:125–135. https://doi.org/10.1042/BSR20100026

    Article  CAS  PubMed  Google Scholar 

  • Huang Y, Verheesen P, Roussis A, Frankhuizen W, Ginjaar I, Haldane F, Laval S, Anderson LVB, Verrips T, Frants RR, de Haard H, Bushby K, den Dunnen J, van der Maarel SM (2005) Protein studies in dysferlinopathy patients using llama-derived antibody fragments selected by phage display. Eur J Hum Genet 13:721–730. https://doi.org/10.1038/sj.ejhg.5201414

    Article  CAS  PubMed  Google Scholar 

  • I. Richard, C. Roudaut, A. Saenz, R. Pogue, J.E.M.A. Grimbergen, L.V.B. Anderson, C. Beley, A-M Cobo, C. de Diego, B. Eymard, P. Gallano, H.B. Ginjaar, A. Lasa, C. Pollitt, H. Topaloglu, J.A. Urtizberea, M. de Visser, A. van der Kooi, K. Bushby, E. Bakker, A. Lopez de Munain, M. Fardeau, J.S. Beckmann, (1999) Calpainopathy—A Survey of Mutations and Polymorphisms. The American Journal of Human Genetics 64 (6):1524-1540.

    Article  CAS  Google Scholar 

  • Jackman RW et al (2004) The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 4:834–4–843.

    Google Scholar 

  • Jennifer M. Thompson M, Moore SA, Liewluck T (2018) A novel CAPN3 mutation in late-onset limb-girdle muscular dystrophy with early respiratory insufficiency. Journal of Clinical Neuroscience 53:229-231.

    Article  CAS  Google Scholar 

  • Kaplan J-C, Hamroun D, Rivier F, Bonne G (2016) The 2017 version of the gene table of monogenic neuromuscular disorders (nuclear genome). Neuromuscul Disord 26:895–929. https://doi.org/10.1016/j.nmd.2016.11.010

    Article  Google Scholar 

  • Kramerova I, Beckmann JS, Spencer MJ (2007) Molecular and cellular basis of calpainopathy (limb-girdle muscular dystrophy type 2A). Biochim Biophys Acta 1772:128–144. https://doi.org/10.1016/j.bbadis.2006.07.002

    Article  CAS  PubMed  Google Scholar 

  • Kramerova I, Kudryashova E, Tidball JG, Spencer MJ (2004) Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro. Hum Mol Genet 13:1373–1388. https://doi.org/10.1093/hmg/ddh153

    Article  CAS  PubMed  Google Scholar 

  • Kramerova I, Kudryashova E, Venkatraman G, Spencer MJ (2005) Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway. Hum Mol Genet 14:2125–2134. https://doi.org/10.1093/hmg/ddi217

    Article  CAS  PubMed  Google Scholar 

  • Lennon NJ, Kho A, Bacskai BJ, Perlmutter SL, Hyman BT, Brown RH Jr (2003) Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J Biol Chem 278:50466–50473. https://doi.org/10.1074/jbc.M307247200

    Article  CAS  PubMed  Google Scholar 

  • Nigro V, Savarese M (2014) Genetic basis of limb-girdle muscular dystrophies: the 2014 update. Acta Myol 33:1–12.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ono Y, Ojima K, Shinkai-Ouchi F, Hata S, Sorimachi H (2016) An eccentric calpain, CAPN3/p94/calpain-3. Biochimie 122:169–187. https://doi.org/10.1016/j.biochi.2015.09.010

    Article  CAS  PubMed  Google Scholar 

  • Ono Y, Shimada H, Sorimachi H, Richard I, Saido TC, Beckmann JS, Ishiura S, Suzuki K (1998) Functional defects of a muscle-specific Calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A. J Biol Chem 273:17073–17078. https://doi.org/10.1074/jbc.273.27.17073

    Article  CAS  PubMed  Google Scholar 

  • Park HJ, Jang H, Lee JH, Shin HY, Cho SR, Park KD, Bang D, Lee MG, Kim SM, Lee JH, Choi YC (2016) Clinical and pathological heterogeneity of Korean patients with CAPN3 mutations. Yonsei Med J 57:173–179. https://doi.org/10.3349/ymj.2016.57.1.173

    Article  CAS  PubMed  Google Scholar 

  • Piluso G, Politano L, Aurino S, Fanin M, Ricci E, Ventriglia VM, Belsito A, Totaro A, Saccone V, Topaloglu H, Nascimbeni AC, Fulizio L, Broccolini A, Canki-Klain N, Comi LI, Nigro G, Angelini C, Nigro V (2005) Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes. J Med Genet 42:686–693. https://doi.org/10.1136/jmg.2004.028738

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rumiko Izumi, Tetsuya Niihori, Toshiaki Takahashi, Naoki Suzuki, Maki Tateyama, Chigusa Watanabe, Kazuma Sugie, Hirotaka Nakanishi, Gen Sobue, Masaaki Kato, Hitoshi Warita, Yoko Aoki, Masashi Aoki, (2015) Genetic profile for suspected dysferlinopathy identified by targeted next-generation sequencing. Neurology Genetics 1 (4):e36.

    Article  Google Scholar 

  • Shenkman BS, Belova SP, Lomonosova YN, Kostrominova TY, Nemirovskaya TL (2015) Calpain-dependent regulation of the skeletal muscle atrophy following unloading. Arch Biochem Biophys 584:36–41.

    Article  CAS  Google Scholar 

  • Sorimachi H, Hata S, Ono Y (2011) Impact of genetic insights into calpain biology. J Biochem 150:23–37. https://doi.org/10.1093/jb/mvr070

    Article  CAS  PubMed  Google Scholar 

  • Srujana et al (2012) Quality control in aminoacyl-tRNA synthesis. Advances in Protein Chemistry and Structural Biology. Adv Protein Chem Struct Bio:1–43. https://doi.org/10.1016/b978-0-12-386497-0.00001-3

    Google Scholar 

  • Straub V, Murphy A, Udd B, LGMD workshop study group (2018) 229th ENMC international workshop: limb-girdle muscular dystrophies - nomenclature and reformed classification Naarden, the Netherlands, 17-19 March 2017. Neuromuscul Disord 28:702–710. https://doi.org/10.1016/j.nmd.2018.05.007

    Article  PubMed  Google Scholar 

  • Urtasun M, Sáenz A, Roudaut C et al (1998) Limb-girdle muscular dystrophy in Guipúzcoa (Basque Country, Spain). Brain 121(Pt 9):1735–1747.

    Article  Google Scholar 

  • Ye Q, Campbell RL, Davies PL (2018) Structures of human calpain-3 protease core with and without bound inhibitor reveal mechanisms of calpain activation. J Biol Chem 293:4056–4070. https://doi.org/10.1074/jbc.RA117.001097

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We would like to thank the genomic platform members in IMRB (Institut Mondor de Recherche Biomédicale), all the staff of the Department of Neurology, as well as all the staff of the Laboratory of Pathology, Habib Bourguiba University Hospital in Sfax. We also thank Chokri Khalaf for proofreading the study.

Funding

This work was supported by the “Association Française contre les Myopathies” Translamuscle #19507.

Author information

Authors and Affiliations

  1. Laboratory of Neurogenetics, Parkinson’s Disease and Cerebrovascular Disease (LR-12-SP-19), University Hospital Habib Bourguiba, Sfax, Tunisia

    Sabrine Rekik, Salma Sakka, Sawssan Ben Romdhan, Nouha Farhat & Chokri Mhiri

  2. Clinical Investigation Center (CIC), CHU Habib Bourguiba, Sfax, Tunisia

    Sabrine Rekik, Sawssan Ben Romdhan & Chokri Mhiri

  3. U955-IMRB, Team 10, Biology of the Neuromuscular System, Inserm, UPEC, Créteil, France

    Yasmine Baba Amer & François Jérôme Authier

  4. Anatomopathology Laboratory, CHU Habib Bourguiba, Sfax, Tunisia

    Leila Lehkim

Authors
  1. Sabrine Rekik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Salma Sakka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sawssan Ben Romdhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nouha Farhat
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yasmine Baba Amer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Leila Lehkim
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. François Jérôme Authier
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chokri Mhiri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sabrine Rekik.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rekik, S., Sakka, S., Ben Romdhan, S. et al. Novel Missense CAPN3 Mutation Responsible for Adult-Onset Limb Girdle Muscular Dystrophy with Calves Hypertrophy. J Mol Neurosci 69, 563–569 (2019). https://doi.org/10.1007/s12031-019-01383-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-019-01383-z

Keywords

Search

Navigation